European Archives - Page 48 of 1131 - European Medical Journal

EBMT 2025: Transplantation Outcomes in MDS/AML

Explore EBMT 2025 results on transplantation outcomes for Myelodysplastic Syndrome and Acute Myeloid Leukaemia, highlighting survival and relapse data.

EBMT 2025: Adoptive Cell Therapy for Infections in Immunocompromised

Adoptive cell therapy with memory T lymphocytes clears infections in patients that are immunocompromised, showing promising results at EBMT 2025.

EBMT 2025: Are Functional Respiratory Tests Key for Screening in CAR-T Cell Therapy?

Functional respiratory tests may help predict outcomes in anti-CD19 CAR-T cell therapy, as shown in EBMT 2025 research.

EBMT 2025: Maintenance Therapy Improves High-Risk AML Outcomes

Maintenance therapy significantly boosts outcomes for high-risk AML patients after transplantation, as highlighted at EBMT 2025.

How Clinicians’ Expectations Shape AI Diagnostic Tools’ Success

New research has examined what drives clinicians to adopt intelligence-enabled diagnostic clinical decision support systems, and how to improve uptake.

New AI Tool May Reveal Rheumatoid Arthritis Risk in Infancy

Researchers introduce a new Genetic Progression Score (GPS) that enhances prediction of autoimmune disease progression by integrating biobank and case-control genetic data.

Men with PCOS-Affected Sisters Show Higher Diabetes Risks

A large cohort study from Sweden reveals that men with sisters diagnosed with polycystic ovary syndrome (PCOS) face elevated cardiometabolic risks as early as adolescence.

Shaji Kumar

Hema Now: Episode 14: Personalised Approaches in Myeloma Treatment

Shaji Kumar, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

An illustrated older man and woman cycling on bikes and looking happy and healthy

The clock, the germ and the gut: Pharma’s role in healthy ageing

How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial innovation.

Delays in Sepsis Antibiotics Double Mortality Risk

Administering antibiotics more than 1 hour after emergency department presentation for suspected sepsis significantly increases the risk of 28-day in-hospital mortality.